HomeNRSN • NASDAQ
add
Neurosense Therapeutics Ltd
Previous close
$1.16
Day range
$1.12 - $1.33
Year range
$0.67 - $2.60
Market cap
28.96M USD
Avg Volume
345.13K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.35M | -22.57% |
Net income | -2.35M | -174.74% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -2.34M | 22.57% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 666.00K | -44.87% |
Total assets | 1.68M | -8.53% |
Total liabilities | 2.20M | -37.84% |
Total equity | -519.00K | — |
Shares outstanding | 24.60M | — |
Price to book | -58.00 | — |
Return on assets | -348.28% | — |
Return on capital | 1,130.06% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -2.35M | -174.74% |
Cash from operations | -2.00M | — |
Cash from investing | -6.50K | — |
Cash from financing | 650.50K | — |
Net change in cash | -1.36M | — |
Free cash flow | -1.32M | — |
About
Founded
2017
Website
Employees
17
